Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review

被引：109
作者：
Zhang, Fan [1 ]
Zhang, Yuanyuan [1 ]
Zhao, Weiwei [1 ]
Deng, Kui [1 ]
Wang, Zhuozhong [1 ]
Yang, Chunyan [1 ]
Ma, Libing [1 ]
Openkova, Margarita S. [2 ]
Hou, Yan [1 ]
Li, Kang [1 ]
机构：
[1] Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Harbin, Peoples R China
[2] Harbin Med Univ, Harbin, Peoples R China
来源：
ONCOTARGET | 2017年 / 8卷 / 21期
基金：
中国国家自然科学基金;
关键词：
systematic review; metabolomics; CRC; biomarkers; pathway; CHROMATOGRAPHY-MASS-SPECTROMETRY; MARKERS EGTM GUIDELINES; NMR-SPECTROSCOPY; EUROPEAN GROUP; TUMOR-MARKERS; SERUM; METABONOMICS; METABOLISM; PATHWAY; PROGRESSION;
D O I：
10.18632/oncotarget.16727
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive techniques that have achieved colorectal cancer (CRC) diagnosis, prognosis, survival and recurrence in clinic. To investigate colorectal cancer metabolism, we perform an electronic literature search, from 1998 to January 2016, for studies evaluating the metabolomic profile of patients with CRC regarding the diagnosis, recurrence, prognosis/survival, and systematically review the twenty-three literatures included. QUADOMICS tool was used to assess the quality of them. We highlighted the metabolism perturbations based on metabolites and pathway. Metabolites related to cellular respiration, carbohydrate, lipid, protein and nucleotide metabolism were significantly altered in CRC. Altered metabolites were also related to prognosis, survival and recurrence of CRC. This review could represent the most comprehensive information and summary about CRC metabolism to date. It certificates that metabolomics had great potential on both discovering clinical biomarkers and elucidating previously unknown mechanisms of CRC pathogenesis.
引用
收藏
页码：35460 / 35472
页数：13
相关论文
共 54 条
[1]   Metabolomics in cancer biomarker discovery: Current trends and future perspectives [J].
Armitage, Emily G. ;
Barbas, Coral .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 87 :1-11
[2]   Cancer metabolism: fatty acid oxidation in the limelight [J].
Carracedo, Arkaitz ;
Cantley, Lewis C. ;
Pandolfi, Pier Paolo .
NATURE REVIEWS CANCER, 2013, 13 (04) :227-232
[3]   Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS) [J].
Chan, Eric Chun Yong ;
Koh, Poh Koon ;
Mal, Mainak ;
Cheah, Peh Yean ;
Eu, Kong Weng ;
Backshall, Alexandra ;
Cavill, Rachel ;
Nicholson, Jeremy K. ;
Keun, Hector C. .
JOURNAL OF PROTEOME RESEARCH, 2009, 8 (01) :352-361
[4]   Distinct Urinary Metabolic Profile of Human Colorectal Cancer [J].
Cheng, Yu ;
Xie, Guoxiang ;
Chen, Tianlu ;
Qiu, Yunping ;
Zou, Xia ;
Zheng, Minhua ;
Tan, Binbin ;
Feng, Bo ;
Dong, Taotao ;
He, Pingang ;
Zhao, Linjing ;
Zhao, Aihua ;
Xu, Lisa X. ;
Zhang, Yan ;
Jia, Wei .
JOURNAL OF PROTEOME RESEARCH, 2012, 11 (02) :1354-1363
[5]   A Prospective Study of Serum Metabolites and Colorectal Cancer Risk [J].
Cross, Amanda J. ;
Moore, Steven C. ;
Boca, Simina ;
Huang, Wen-Yi ;
Xiong, Xiaoqin ;
Stolzenberg-Solomon, Rachael ;
Sinha, Rashmi ;
Sampson, Joshua N. .
CANCER, 2014, 120 (19) :3049-3057
[6]   The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation [J].
DeBerardinis, Ralph J. ;
Lum, Julian J. ;
Hatzivassiliou, Georgia ;
Thompson, Craig B. .
CELL METABOLISM, 2008, 7 (01) :11-20
[7]   The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells [J].
Derdak, Zoltan ;
Mark, Nicholas M. ;
Beldi, Guido ;
Robson, Simon C. ;
Wands, Jack R. ;
Baffy, Gyoergy .
CANCER RESEARCH, 2008, 68 (08) :2813-2819
[8]   Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer [J].
Dowling, Paul ;
Hughes, David J. ;
Larkin, Anne Marie ;
Meiller, Justine ;
Henry, Michael ;
Meleady, Paula ;
Lynch, Vincent ;
Pardini, Barbara ;
Naccarati, Alessio ;
Levy, Miroslav ;
Vodicka, Pavel ;
Neary, Paul ;
Clynes, Martin .
CLINICA CHIMICA ACTA, 2015, 441 :133-141
[9]   Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use [J].
Duffy, M. J. ;
van Dalen, A. ;
Haglund, C. ;
Hansson, L. ;
Holinski-Feder, E. ;
Klapdor, R. ;
Lamerz, R. ;
Peltomaki, P. ;
Sturgeon, C. ;
Topolcan, O. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (09) :1348-1360
[10]   Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines [J].
Duffy, MJ ;
van Dalen, A ;
Haglund, C ;
Hansson, L ;
Klapdor, R ;
Lamerz, R ;
Nilsson, O ;
Sturgeon, C ;
Topolcan, O .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (06) :718-727
123456